Literature DB >> 6286014

Changes in cell surface antigen expression during hemopoietic differentiation.

C Sieff, D Bicknell, G Caine, J Robinson, G Lam, M F Greaves.   

Abstract

Human bone marrow cells were separated on a fluorescence activated cell sorter (FACS) according to their binding of a series of monoclonal antibodies; the positive and negative fractions were cloned for erythroid burst and colony-forming units (BFU-E and CFU-E) and myeloid colony-forming units (CFU-GM), and cytocentrifuge slides were prepared for microscopy of maturing precursors. The pattern of antigen expression on hemopoietic progenitor and precursor populations has been established using antibodies defining blood group (A, I/i), HLA-associated (*A, B, C, DR, DC1), lineage specific, and transferrin receptor antigens. Like monomorphic HLA-DR, the antigen defined by monoclonal antibody OKT10 is expressed on the earliest progenitors and lost during differentiation, suggesting a role in interactions regulating the differentiation of these cells. The HLA-linked DC1 determinant, in contrast to HLA-DR, is not expressed at a detectable level on progenitor cells. Although a lineage-specific early antigen has not been identified, the transferrin receptor is expressed on the majority of erythroid progenitors, but only weakly on myeloid progenitors, and may provide an approach to isolating erythroid progenitors. These and earlier studies with monoclonal antibodies against HLA-DR and glycophorin now provide a detailed "map" of antigen expression during hemopoietic differentiation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286014

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  34 in total

1.  MafB is an inducer of monocytic differentiation.

Authors:  L M Kelly; U Englmeier; I Lafon; M H Sieweke; T Graf
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

2.  HLA-class II antigens on human hematopoietic progenitors.

Authors:  F W Busch; M Langer; G Pawelec; A Ziegler; P Wernet; H J Bühring; P Meyer; C Müller
Journal:  Blut       Date:  1987-03

3.  Haemopoiesis in human fetal and embryonic liver. Immunohistochemical determination in B5-fixed paraffin-embedded tissues.

Authors:  W Timens; W A Kamps; T Rozeboom-Uiterwijk; S Poppema
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 4.  Molecular characterization of CD34+ human hematopoietic progenitor cells.

Authors:  W Knapp; H Strobl; C Scheinecker; C Bello-Fernandez; O Majdic
Journal:  Ann Hematol       Date:  1995-06       Impact factor: 3.673

5.  Isolation and transcriptome analyses of human erythroid progenitors: BFU-E and CFU-E.

Authors:  Jie Li; John Hale; Pooja Bhagia; Fumin Xue; Lixiang Chen; Julie Jaffray; Hongxia Yan; Joseph Lane; Patrick G Gallagher; Narla Mohandas; Jing Liu; Xiuli An
Journal:  Blood       Date:  2014-10-22       Impact factor: 22.113

6.  Granulocyte and monocyte surface membrane markers in the myelodysplastic syndromes.

Authors:  R E Clark; T G Hoy; A Jacobs
Journal:  J Clin Pathol       Date:  1985-03       Impact factor: 3.411

7.  Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor.

Authors:  Patrick P Ng; Gustavo Helguera; Tracy R Daniels; Simon Z Lomas; Jose A Rodriguez; Gary Schiller; Benjamin Bonavida; Sherie L Morrison; Manuel L Penichet
Journal:  Blood       Date:  2006-06-27       Impact factor: 22.113

8.  Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells.

Authors:  P J Voogt; E Goulmy; W E Fibbe; W F Veenhof; A Brand; J H Falkenburg
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

9.  Presence of the Tn antigen on hematopoietic progenitors from patients with the Tn syndrome.

Authors:  W Vainchenker; G Vinci; U Testa; A Henri; A Tabilio; M P Fache; H Rochant; J P Cartron
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

Review 10.  Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.

Authors:  Stephanie Tortorella; Tom C Karagiannis
Journal:  J Membr Biol       Date:  2014-02-27       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.